Come up with a name for your new list and we'll add to it:
CoStim Pharmaceuticals was acquired by
Novartis on February 17, 2014.
CoStim Pharmaceuticals is a biotechnology company focused on harnessing a patient's own immune system by blocking the suppressive signals from cancer that shut down the immune response. CoStim has lat…